• Issue

    HemaSphere: Volume 7, Issue 3

    March 2023
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

HemaTopics

Open Access

LiveSeq: A New Technique to Sample RNA From Cells Without Killing Them

David G. Kent, 
  • First Published: 17 February 2023

Letter

Open Access

Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study

Judith Trotman,  Peter Presgrave,  Duncan P. Carradice,  Douglas Stuart Lenton,  Maher K. Gandhi,  Tara Cochrane,  Xavier Badoux,  Julia Carlson,  Gloria Nkhoma,  Belinda Butcher,  Armin Nikpour,  Michael Fulham,  Anna M. Johnston, 
  • First Published: 21 February 2023

Article

Open Access

Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden

Caroline E. Weibull,  Tove Wästerlid,  Björn Engelbrekt Wahlin,  Per-Ola Andersson,  Sara Ekberg,  Sandra Lockmer,  Gunilla Enblad,  Michael J. Crowther,  Eva Kimby,  Karin E. Smedby, 
  • First Published: 23 February 2023
Open Access

Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic Leukemia

Sebastian Faehling,  Mariana Coelho,  Alessia Floerchinger,  Christof Schneider,  Stephan Stilgenbauer,  Peter Lichter,  Martina Seiffert,  Philipp M. Roessner, 
  • First Published: 22 February 2023
Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic Leukemia

Guideline Article - Expert opinion

Open Access

Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel

Livio Pagano,  Pier Luigi Zinzani,  Stefano Pileri,  Pietro Quaglino,  Branko Cuglievan,  Emilio Berti,  Naveen Pemmaraju,  Francesco Onida,  Rein Willemze,  Alberto Orfao,  Giovanni Barosi, 
  • First Published: 21 February 2023

Editorial

Open Access

A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care

Tarec Christoffer El-Galaly,  Verena I. Gaidzik,  Mihnea-Alexandru Gaman,  Darko Antic,  Jessica Okosun,  Mhairi Copland,  Veronika Sexl,  Adele K. Fielding,  Robin Doeswijk,  Helen Parker,  Martin Dreyling,  Konstanze Döhner,  António Medina Almeida,  Elizabeth Macintyre,  John G. Gribben,  Kirsten Grønbæk,  on behalf of the EHA Diversity, Equity, and Inclusion Taskforce , 
  • First Published: 21 February 2023

Article

Open Access

Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial

Katja Weisel,  Meletios A. Dimopoulos,  Jesús San-Miguel,  Agne Paner,  Monika Engelhardt,  Fiona Taylor,  Jennifer Lord-Bessen,  Christine Yip,  Mike Greenwood,  Jackson Tang,  Michele Cavo, 
  • First Published: 24 February 2023

Comment

Open Access

Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet

Anna Collado,  Maria Paola Boaro,  Sigrid van der Veen,  Amira Idrizovic,  Bart J. Biemond,  David Beneitez Pastor,  Ana Ortuño,  Elena Cela,  Anna Ruiz-Llobet,  Pablo Bartolucci,  Marianne de Montalembert,  Gastone Castellani,  Riccardo Biondi,  Renzo Manara,  Tiziana Sanavia,  Piero Fariselli,  Petros Kountouris,  Marina Kleanthous,  Federico Alvarez,  Santiago Zazo,  Raffaella Colombatti,  Eduard J. van Beers,  María del Mar Mañú-Pereira, 
  • First Published: 22 February 2023

Article

Open Access

Autoimmune Lymphoproliferative Syndrome (ALPS) Disease and ALPS Phenotype: Are They Two Distinct Entities?

Elena Palmisani,  Maurizio Miano,  Alice Grossi,  Marina Lanciotti,  Michela Lupia,  Paola Terranova,  Isabella Ceccherini,  Eugenia Montanari,  Michaela Calvillo,  Filomena Pierri,  Concetta Micalizzi,  Rosario Maggiore,  Daniela Guardo,  Sabrina Zanardi,  Elena Facchini,  Angela Maggio,  Elena Mastrodicasa,  Paola Corti,  Giovanna Russo,  Marta Pillon,  Piero Farruggia,  Simone Cesaro,  Angelica Barone,  Francesca Tosetti,  Ugo Ramenghi,  Nicoletta Crescenzio,  Jack Bleesing,  Carlo Dufour,  Francesca Fioredda, 
  • First Published: 22 February 2023
Open Access

Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis

Sjoerd J. F. Hermans,  Jurjen Versluis,  Myriam Labopin,  Sebastian Giebel,  Yvette van Norden,  Ivan Moiseev,  Didier Blaise,  Jose L. Díez Martín,  Ellen Meijer,  Montserrat Rovira,  Goda Choi,  Anna Maria Raiola,  Yener Koc,  Péter Reményi,  Jan Vydra,  Nicolaus Kröger,  Simona Sica,  Massimo Martino,  Gwendolyn van Gorkom,  Patrice Chevallier,  Alessandro Busca,  Concepcion Herrera Arroyo,  Eolia Brissot,  Zinaida Peric,  Arnon Nagler,  Roni Shouval,  Fabio Ciceri,  Jan J. Cornelissen,  Mohamad Mohty, 
  • First Published: 21 February 2023
Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis

Letter

Open Access

Impact of Mutational Status and Prognostic Factors on Survival in Chronic Myelomonocytic Leukemia With Systemic Inflammation and Autoimmune Disorders

Charles Dussiau,  Henry Dupuy,  Audrey Bidet,  Mathieu Sauvezie,  Anne-Charlotte De-Grande,  Lisa Boureau,  Etienne Riviere,  Edouard Forcade,  Fabrice Bonnet,  Pierre-Yves Dumas,  Pierre Duffau,  Arnaud Pigneux,  Jean-François Viallard,  Sophie Dimicoli-Salazar,  Estibaliz Lazaro, 
  • First Published: 23 February 2023

Article

Open Access

In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury

Enrica Federti,  Alessandro Matte,  Antonio Recchiuti,  Francesca Garello,  Alessandra Ghigo,  Wassim El Nemer,  Enzo Terreno,  Angela Amoresano,  Domenico Mattoscio,  Franco Turrini,  Christophe Lebouef,  Anne Janin,  Antonella Pantaleo,  Roberta Russo,  Mickael Marin,  Iana Iatcencko,  Veronica Riccardi,  Angela Siciliano,  Achille Iolascon,  Carlo Brugnara,  Lucia De Franceschi, 
  • First Published: 28 February 2023
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury

Letter

Open Access

Excessive Erythrocytosis Is Not Associated With Altered Iron Homeostasis in Men From the World's Highest City

Gaetano Cairo,  Benoit Champigneulle,  Margherita Correnti,  Elena Gammella,  Stefania Recalcati,  Domenico Girelli,  Annalisa Castagna,  Anne-Kristine Meinild Lundby,  Ivan Hancco,  Carole Chirica,  Dorra Guergour,  Laura Oberholzer,  Emeric Stauffer,  Carsten Lundby,  Aurélien Pichon,  Julien V Brugniaux,  Stéphane Doutreleau,  Samuel Verges,  Paul Robach, 
  • First Published: 22 February 2023

HemaTopics

Open Access

Elevated Transferrin at High Altitude: Trick or Treat?

Francesca Vinchi, 
  • First Published: 23 February 2023

Letter

Open Access

DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients

Federica Malighetti,  Giulia Arosio,  Chiara Manfroni,  Mario Mauri,  Matteo Villa,  Beatrice Manghisi,  Elena Inzoli,  Giovanni Rindone,  Giovanni P. M. Zambrotta,  Ivan Civettini,  Veronica Guglielmana,  Daniele Ramazzotti,  Giovanni Giudici,  Silvia Bombelli,  Roberto Perego,  Rocco Piazza,  Luca Mologni,  Carlo Gambacorti-Passerini, 
  • First Published: 24 February 2023

Article

Open Access

The CKS1/CKS2 Proteostasis Axis Is Crucial to Maintain Hematopoietic Stem Cell Function

William Grey,  Samantha Atkinson,  Beatrice Rix,  Pedro Casado,  Linda Ariza-McNaughton,  Cathy Hawley,  Miriam L. Sopoena,  Katherine S. Bridge,  David Kent,  Pedro R. Cutillas,  Dominique Bonnet, 
  • First Published: 28 February 2023

Correction Notice

Open Access

Correction Notice: Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma

  • First Published: 22 February 2023